B
BP8
vs
S
S&P/ASX 300
Over the past 12 months, BP8 has underperformed S&P/ASX 300, delivering a return of -43% compared to the S&P/ASX 300's +7% growth.
Stocks Performance
BP8 vs S&P/ASX 300
Performance Gap
BP8 vs S&P/ASX 300
Performance By Year
BP8 vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
BPH Global Ltd
Glance View
BPH Global Ltd is a AU-based company operating in Biotechnology industry. The company is headquartered in Sydney, New South Wales. The company went IPO on 2000-06-13. BPH Global Ltd, formerly Stemcell United Limited, is a plant-focused biotechnology company. The firm is focused on producing foods and products that deliver Traditional Chinese Medicine-based health outcomes. The firm focuses on the research and development, production and commercialization of plant-based products, including seaweed and sea plants to produce sustainable plant-based protein foods and nutraceutical and pharmaceutical ingredients (including cannabidiol (CBD) extracted from Hemp) for utilization in the food, nutrition, healthcare, health supplements, cosmetics, and personal care industries. Its principal business focus is on Singapore, Australia, Southeast Asia, and Chinese markets. Its subsidiaries include Stemcell United Pte Ltd, Stemcell Essential Pte Ltd, SCU (HK) Ltd, Yunnan Huafang Industrial Hemp Co Ltd, SCU Southeast Asia Sdn Bhd, SCU Lab Pty Ltd, Shenzhen Lantene Dingzhi Biotechnology Co Ltd, Hainan SCU Biotechnology Co Ltd, and SCU-RY Farm Pte Ltd.
